MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 5821 to 5840 of 5,858 approvalsPage 292 of 293

AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml

Approval Number: SIN00472P
Approval: Apr 22, 1988

AA PHARMA NITROFURANTOIN TABLET 100 mg

Approval Number: SIN00290P
Approval: Apr 21, 1988

RIFAREN 150 CAPSULE 150 mg

Approval Number: SIN00312P
Approval: Apr 21, 1988

DICYNONE INJECTION 250 mg/2 ml

Approval Number: SIN00279P
Approval: Apr 21, 1988

AA PHARMA TRIFLUOPERAZINE TABLET 5 mg

Approval Number: SIN00289P
Approval: Apr 21, 1988

HYDROZIDE TABLET 50 mg

Approval Number: SIN01959P
Approval: Apr 21, 1988
atlantic pharmaceutical (s) pte ltd

PROCARDIN 75 TABLET 75 mg

Approval Number: SIN00263P
Approval: Apr 6, 1988

METHOTREXATE TABLET 2.5 mg

Approval Number: SIN00260P
Approval: Apr 6, 1988

XEPANICOL EYE DROPS 0.5%

Approval Number: SIN00231P
Approval: Apr 5, 1988

TREXAN TABLET 2.5MG

Approval Number: SIN00241P
Approval: Apr 5, 1988

APO-HYDRALAZINE TABLET 10 mg

Approval Number: SIN00211P
Approval: Apr 5, 1988

APO-HYDRALAZINE TABLET 25 mg

Approval Number: SIN00210P
Approval: Apr 5, 1988

CHLORAMPHENICOL EAR DROPS 5% w/v

Approval Number: SIN00230P
Approval: Apr 5, 1988

APO-AMOXI CAPSULE 250 mg

Approval Number: SIN00213P
Approval: Apr 5, 1988

DIRINE INJECTION 20 mg/2 ml

Approval Number: SIN00239P
Approval: Apr 5, 1988
atlantic pharmaceutical (s) pte ltd

LASIX TABLET 40 mg

Approval Number: SIN00199P
Approval: Mar 28, 1988

DICYNONE 500 TABLET 500 mg

Approval Number: SIN00204P
Approval: Mar 28, 1988

PERSANTIN INJECTION 10 mg/2 ml

Approval Number: SIN00206P
Approval: Mar 28, 1988

COTREN VAGINAL TABLETS 500 mg

Approval Number: SIN00175P
Approval: Mar 25, 1988

TRINAZOLE TABLETS 200 mg

Approval Number: SIN00141P
Approval: Mar 21, 1988

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.